Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 23, 2010 | December 30, 2010 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 23, 2010 · Filed December 30, 2010
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 168,071 |
Reported balance
After 2010-12-23 transaction · row 1
1 source rowRow 1 · 2010-12-23 · Gift · Disposed 1,054 · Balance 168,071 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 15,152 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,152 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 28, 2010. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife for daughter | 295 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 295 F2: The reporting person disclaims beneficial ownership of all securities held by his daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife for daughter | 296 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 296 F2: The reporting person disclaims beneficial ownership of all securities held by his daughters. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 28, 2010.
F2: The reporting person disclaims beneficial ownership of all securities held by his daughters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,454 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,672 Underlying: Common shares · 2,454 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,450 | $58.15 | $200,617.50 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,711 Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,200 | $45.45 | $99,987.36 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,454 | $41.03 | $100,691.79 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2007 Filed Apr 3, 2007 19:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,381 | $55.76 | $77,004.56 |
DisclosureSEC source: 0001104659-07-025418 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,507 Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $53.40 | $0.00 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · derivative · entry 16 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: common shares · 11,000 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 7,530 | $0.00 Strike: $53.40 | $0.00 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · derivative · entry 15 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,530 Underlying: common shares · 7,530 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 16,187 | $0.00 Strike: $53.40 | $0.00 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · derivative · entry 14 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,187 Underlying: common shares · 16,187 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 10,067 | $0.00 Strike: $53.40 | $0.00 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · derivative · entry 13 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,067 Underlying: common shares · 10,067 shares Expires 2009-02-11 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to by) · Derivative | 12,794 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · derivative · entry 12 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,126 Underlying: Common Shares · 12,794 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to by) · Derivative | 8,761 | $0.00 Strike: $41.01 | $0.00 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · derivative · entry 11 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 8,761 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to by) · Derivative | 18,666 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · derivative · entry 10 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 18,666 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to by) · Derivative | 11,703 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · derivative · entry 9 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 11,703 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon Shares without par value | 44,784 | $53.40 | $2,391,465.60 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · nonDerivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,888 Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 12,794 | $41.03 | $524,959.57 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 8,761 | $41.01 | $359,288.61 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 18,666 | $41.69 | $778,185.54 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2007 Filed Mar 13, 2007 22:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 11,703 | $42.50 | $497,351.75 |
DisclosureSEC source: 0001104659-07-018763 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2007 Filed Feb 20, 2007 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,776 | $52.49 | $93,222.24 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,748 Read SEC document |
| February 18, 2007 Filed Feb 20, 2007 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,222 | $52.49 | $64,142.78 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,524 Read SEC document |
| February 17, 2007 Filed Feb 20, 2007 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,486 | $52.49 | $182,980.14 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,746 Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 112,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · derivative · entry 11 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: common shares · 112,000 shares Expires 2017-02-15 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 37,334 on 2/16/2008, 37,333 on 2/16/09, and 37,333 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 21,000 | $52.54 | $1,103,340.00 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,786 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 27,600 | $52.54 | $1,450,104.00 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,786 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,554 | $52.70 | $345,395.80 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,232 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,800 | $52.81 | $95,059.80 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,186 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 5,479 | $0.00 Strike: $52.25 | $0.00 |
DisclosureSEC source: 0001104659-07-006230 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,479 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,819 | $0.00 Strike: $40.93 | $0.00 |
DisclosureSEC source: 0001104659-07-006230 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,819 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,298 | $52.57 | $436,225.86 |
DisclosureSEC source: 0001104659-07-006230 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,986 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 5,479 | $52.25 | $286,293.64 |
DisclosureSEC source: 0001104659-07-006230 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,819 | $40.93 | $115,376.88 |
DisclosureSEC source: 0001104659-07-006230 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2006 Filed Aug 3, 2006 22:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,156 | $47.35 | $149,420.82 |
DisclosureSEC source: 0001104659-06-051250 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,986 Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,362 | $0.00 Strike: $42.90 | $0.00 |
DisclosureSEC source: 0001104659-06-045425 · a4.xml · derivative · entry 9 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,362 Underlying: Common shares · 2,362 shares Expires 2013-02-13 F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,050 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-045425 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,050 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 15,033 | $0.00 Strike: $42.90 | $0.00 |
DisclosureSEC source: 0001104659-06-045425 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,033 Underlying: Common shares · 15,033 shares Expires 2013-02-13 F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 17,409 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-045425 · a4.xml · derivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 822 Underlying: Common shares · 17,409 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 17,395 | $42.90 | $746,245.50 |
DisclosureSEC source: 0001104659-06-045425 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,142 Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 20,459 | $33.23 | $679,881.21 |
DisclosureSEC source: 0001104659-06-045425 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2006 Filed Feb 22, 2006 23:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 310 | $43.86 | $13,596.60 |
DisclosureSEC source: 0001104659-06-011242 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,078 Read SEC document |
| February 18, 2006 Filed Feb 22, 2006 23:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 913 | $44.15 | $40,308.95 |
DisclosureSEC source: 0001104659-06-011242 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,888 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 23:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011242 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2016-02-16 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/17/2007, 27,667 on 02/17/2008 and 27,666 on 02/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 23:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011242 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,388 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,286 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0001104659-06-010258 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,286 Underlying: Common shares · 2,286 shares Expires 2008-02-12 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-06-010258 · a4.xml · derivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,286 | $43.73 | $99,966.78 |
DisclosureSEC source: 0001104659-06-010258 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,801 Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-06-010258 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 17,954 | $0.00 Strike: $42.94 | $0.00 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · derivative · entry 10 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,954 Underlying: Common shares · 17,954 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 21,281 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · derivative · entry 9 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,281 Underlying: Common shares · 21,281 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,063 | $0.00 Strike: $40.93 | $0.00 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,063 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 17,954 | $42.94 | $770,944.76 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,212 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.